Compare care options for Obsessive-Compulsive Disorder

See what we know about each option. We may not have all options. This page does not pick one for you.

Pick up to 4 care options

You can share this page. You do not need an account.

4 selected

What we found

Each option is for Obsessive-Compulsive Disorder. Research and local care are different facts.

Fluoxetine

What it is

We have not added a short description yet.

Why it is on this page

People: adults and pediatric patients 7 to 17 years of age with Obsessive Compulsive Disorder (OCD), as labeled

DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026

Relationship: labeled indication

Scope: country:US

Pointer: /sections/1

Open source

Source: DailyMed fluoxetine hydrochloride label. Checked Sep 19, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/f274f102-67ec-46e7-b248-533be2e3003b.xml

Research for Obsessive-Compulsive Disorder

Not reviewed

No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.

Compared with the others: Not directly compared. We show each option’s own research.

See the researchFind care

CLOMIPRAMINE HYDROCHLORIDE

What it is

We have not added a short description yet.

Why it is on this page

People: patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age

DailyMed clomipramine (Anafranil) label · checked Sep 18, 2026

Relationship: labeled indication

Scope: country:US

Pointer: /sections/0

Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

Open source

Source: DailyMed clomipramine (Anafranil) label. Checked Sep 18, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/4074b555-7635-41a9-809d-fae3b3610059.xml

Research for Obsessive-Compulsive Disorder

Not reviewed

No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.

Compared with the others: Not directly compared. We show each option’s own research.

See the researchFind care

Exposure and response prevention therapy (ERP)

What it is

Exposure and response prevention (ERP) is a form of CBT that NICE includes among treatment options for adults with OCD, within the scope of its guideline recommendation.

Official guideline documents · checked Aug 24, 2026

Relationship: supports

Scope: global

Pointer: /document/recommendation

Source: Official guideline documents. Checked Aug 24, 2026. Scope: global.

Why it is on this page

People: niños y adolescentes con TOC

GuíaSalud GPC 634: TOC en niños y adolescentes · checked Aug 30, 2026

Relationship: recomendado para población pediátrica con TOC

Scope: country:ES

Pointer: /recommendations/0

Open source

Source: GuíaSalud GPC 634: TOC en niños y adolescentes. Checked Aug 30, 2026. Scope: country:ES. Link: https://portal.guiasalud.es/wp-content/uploads/2025/02/gpc_634_toc_nino_adolescente_compl.pdf

Why it is on this page

People: adults with OCD

Official guideline documents · checked Aug 24, 2026

Relationship: guideline recommendation

Scope: global

Pointer: /document/recommendation

Source: Official guideline documents. Checked Aug 24, 2026. Scope: global.

Research for Obsessive-Compulsive Disorder

Research suggests benefit in this exact scope

Published Aug 24, 2026 · revision 1

conclusion

For adults with OCD, the retained NICE guideline supports CBT including ERP as a treatment option, with intensity selected to functional impairment and treatment response.

Official guideline documents · checked Aug 24, 2026

Relationship: supports

Scope: global

Pointer: /document/recommendation

Source: Official guideline documents. Checked Aug 24, 2026. Scope: global.

Compared with the others: Not directly compared. We show each option’s own research.

See the researchFind care

Sertraline

What it is

We have not added a short description yet.

Why it is on this page

People: patients with obsessive-compulsive disorder as labeled

DailyMed sertraline (Zoloft) label · checked Sep 18, 2026

Relationship: labeled indication

Scope: country:US

Pointer: /sections/1

Open source

Source: DailyMed sertraline (Zoloft) label. Checked Sep 18, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/fda754f6-d0f3-4dce-a17a-927d64f912f7.xml

Research for Obsessive-Compulsive Disorder

Not reviewed

No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.

Compared with the others: Not directly compared. We show each option’s own research.

See the researchFind care

Page link: https://everyoption.org/compare/ocd?treatments=fluoxetine%2Cclomipramine%2Cerp%2Csertraline